Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2016 06:33 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update

WARREN, N.J., May 10, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the first quarter...
March 21, 2016 06:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Reports 2015 Financial Results and Provides Business Update

– Company Receives Final FDA Confirmation to Initiate Phase 3 Studies Using Next Generation INOpulse Device – – Management to Host a Conference Call Today at 8:30 a.m. ET – WARREN, N.J.,...
March 14, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics to Hold Full Year 2015 Financial Results Conference Call on Monday March 21, 2016

WARREN, N.J., March 14, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will release its full year 2015...
March 04, 2016 17:32 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference

WARREN, N.J., March 04, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will present in the Cowen and...
March 02, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

WARREN, N.J., March 02, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported that in connection with the appointment of...
February 23, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer

WARREN, N.J., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Fabian Tenenbaum as Chief...
February 16, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member

WARREN, N.J., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Mary Ann Cloyd as an...
February 09, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Announces Positive Data From the Final Analysis of the Phase 2 Long-Term Extension Study of INOpulse for Treatment of Pulmonary Arterial Hypertension

WARREN, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive data from the final analysis of...
February 03, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon to Participate in LEERINK Partners 5th Annual Global Healthcare Conference

WARREN, N.J., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will participate in LEERINK...
January 21, 2016 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program

WARREN, N.J., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that the European Patent Office has...